Tumor growth facilitation of exosomal lnc-TAF12–2:1 in vivo. (IMAGE)

Compuscript Ltd

Tumor growth facilitation of exosomal lnc-TAF12–2:1 in vivo. — Caption

(A) Flow chart of the xenograft mouse assay. (B, C) The continuous measurement of tumor growth activity and average weight after injecting exo-lnc-TAF12–2:1. (D) Hematoxylin-eosin staining analyses of tumor tissues after dissection. Immunofluorescence analysis was used to measure the expression of N-cadherin, Ki-67, and ASB12 in animal tumor tissues after extra exosomal lnc-TAF12–2:1 treatment.

Credit

Genes & Diseases

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.

License

CC BY-NC-ND

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.